S?n ph?m In the past Tumor ???c ch? ??nh s? d?ng cho ph? n? trong các tr??ng h?p sau ?ây:Tumor agnostic regulatory approvals can be found for neurotrophic receptor TKI and for pembrolizumab in MSI-superior tumors. Neurotrophic receptor TKI gene fusion [97] is a very exceptional occasion in breast most cancers; it is very Repeated in the exception